All Online

1 - 1 of 1 results


Active filters

Venous Thromboembolism

Until the advent of the COMPASS trial, secondary prevention in patients with peripheral artery disease consisted of either aspirin or clopidogrel monotherapy. A new era is emerging in which, by adding low-dose DOACs to low-dose aspirin, medical therapy may reduce the need for major vascular surgery or endovascular procedures. In this Video Webcast, the faculty will discuss the latest evidence, indications, and guideline-based utilization of dual antiplatelet therapy. In addition to an in-depth look at PAD therapy, participants in this session will receive insights on the latest in secondary prevention options for ESUS and a review of proper dosing for long-term anticoagulation to prevent recurrent events in patients with venous thromboembolic disease.